Are you Dr. Thakkar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1050 W Keswick Ln
Lake Forest, IL 60045Phone+1 847-505-6150- Is this information wrong?
Summary
- Dr. Roopal Thakkar, MD is an internist in Lake Forest, Illinois. He is currently licensed to practice medicine in Illinois.
Education & Training
Wake Forest University School of MedicineFellowship, Nephrology, 2002 - 2003
St Joseph Mercy Ann ArborResidency, Internal Medicine, 2001 - 2002
Wayne State University School of MedicineClass of 1998
Certifications & Licensure
IL State Medical License 2003 - 2017
Clinical Trials
- Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis Start of enrollment: 2006 Nov 01
- An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) Start of enrollment: 2007 Apr 01
- A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD) Start of enrollment: 2007 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- A vision for integrated publicly available information on regulated medical products.Khyati Roberts, Roopal Thakkar, Lina Aljuburi, Donna Boyce, Sean Curtis, Jennifer Dudinak, Helen Fitton, Carlos Garner, Michael Garvin, Susan Longman, Edward Reilly, J...> ;Clinical and Translational Science. 2022 Jun 1
- 5 citationsCreating E‐Labeling Platforms: An Industry VisionKhyati Roberts, Roopal Thakkar, Deborah Autor, Fabio Bisordi, Helen Fitton, Carlos Garner, Michael Garvin, Peter Honig, Mathias Hukkelhoven, Robert Kowalski, Sandra Mi...> ;Clinical Pharmacology and Therapeutics. 2020 Oct 1
- 153 citationsEfficacy and safety of upadacitinib in a randomized trial of patients with Crohn’s diseaseWilliam J. Sandborn, Brian G. Feagan, Edward V. Loftus, Laurent Peyrin-Biroulet, Gert Van Assche, Geert R. D'Haens, Stefan Schreiber, Jean-Frederic Colombel, James D. ...> ;Gastroenterology. 2020 Jun 1
- Join now to see all
Press Mentions
FDA Approves Drug QULIPTA for Chronic MigraineApril 18th, 2023- Update on Withdrawal of Ibrutinib Accelerated Approvals for MCL and MZL in the United StatesApril 14th, 2023
- AbbVie Advances Upadacitinib (RINVOQ®) to Phase 3 Clinical Trials in Systemic Lupus ErythematosusMarch 23rd, 2023
- Join now to see all
